Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

485 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Somaiah N, et al. Among authors: cooper za. Lancet Oncol. 2022 Aug 4:S1470-2045(22)00392-8. doi: 10.1016/S1470-2045(22)00392-8. Online ahead of print. Lancet Oncol. 2022. PMID: 35934010
Survival analysis-time-to-event data and censoring.
Dey T, Lipsitz SR, Cooper Z, Trinh QD, Krzywinski M, Altman N. Dey T, et al. Among authors: cooper z. Nat Methods. 2022 Aug;19(8):906-908. doi: 10.1038/s41592-022-01563-7. Nat Methods. 2022. PMID: 35927476 No abstract available.
485 results